A Crossover Safety Study of Ferumoxytol Versus Placebo

A Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Patients at Risk for Acute Kidney Injury Following Cardiac Surgery.

NCT05524051 ·Status: TERMINATED ·Phase: PHASE2

Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients

NCT00548691 ·Status: COMPLETED ·Phase: PHASE3

A Single Ascending Dose Study of Soluble Ferric Pyrophosphate Administered Intravenously in Healthy Volunteers.

NCT01920854 ·Status: COMPLETED ·Phase: PHASE1

A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease

NCT01155388 ·Status: TERMINATED ·Phase: PHASE3

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis

NCT02174627 ·Status: COMPLETED ·Phase: PHASE3

Single-Dose PK Study of GBT440 in Subjects With Renal Impairment

NCT03161015 ·Status: COMPLETED ·Phase: PHASE1

A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin

NCT00456053 ·Status: COMPLETED ·Phase: PHASE2

Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis

NCT01503021 ·Status: COMPLETED ·Phase: PHASE3

42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia

NCT01381094 ·Status: COMPLETED ·Phase: PHASE2

Study of Aldafermin (NGM282) in Participants With Impaired Renal Function

NCT04179630 ·Status: COMPLETED ·Phase: PHASE1

Study Assessing PK and Safety of MGTA-145 in Subjects With Normal Estimated GFR and Varying Degrees of Renal Impairment

NCT04154670 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease

NCT01971164 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Efficacy of DDO-3055 in Healthy Volunteers and Patients With Chronic Kidney Disease

NCT03976115 ·Status: COMPLETED ·Phase: PHASE1

A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis

NCT01191255 ·Status: COMPLETED ·Phase: PHASE3

A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.

NCT01146574 ·Status: COMPLETED ·Phase: PHASE2

A Dose Escalation and Safety Study of I5NP in Patients Undergoing Major Cardiovascular Surgery

NCT00554359 ·Status: COMPLETED ·Phase: PHASE1

A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor

NCT07187401 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

NCT00428948 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects

NCT01459250 ·Status: COMPLETED ·Phase: PHASE1

Phase 2 Study of Roxadustat in Participants With Anemia and Chronic Kidney Disease Not Requiring Dialysis

NCT00761657 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

NCT00863707 ·Status: COMPLETED ·Phase: PHASE4

Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease

NCT00109291 ·Status: TERMINATED ·Phase: PHASE2

Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease

NCT04523727 ·Status: SUSPENDED ·Phase: PHASE3

Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients

NCT01942460 ·Status: COMPLETED ·Phase: PHASE4

A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

NCT01742585 ·Status: COMPLETED ·Phase: PHASE3